Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r

Molecular and Cellular Proteomics

Volumn 3, Issue 1, 2004, Pages 43-55

  Huber, Martina ^a   Bahr, Inke ^a   Krätzchmar, Jörn R ^a   Becker, Andreas ^a   Müller, Eva Christina ^b   Donner, Peter ^a   Pohlenz, Hans Dieter ^a   Schneider, Martin R ^a   Sommer, Anette ^a  

^a BAYER PHARMA AG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CATHEPSIN D; CELL PROTEIN; FULVESTRANT; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; PROTEINASE; RAB PROTEIN;

BREAST CANCER; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG SENSITIVITY; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEOMICS; REPRODUCIBILITY; REVIEW; RNA ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; PROTEOMICS; RNA, MESSENGER;

EID: 2542550392     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M300047-MCP200     Document Type: Review

References (67)

1. Parczyk, K., and Schneider, M. R. (1996) The future of antihormone therapy: Innovations based on an established principle. J. Cancer Res. Clin. Oncol. 122, 383-396
2. Morris, C., and Wakeling, A. (2002) Fulvestrant ('Faslodex') - A new treatment option for patients progressing on prior endocrine therapy. Endocr. Relat. Cancer 9, 267-276
3. Howell, A., DeFriend, D., Robertson, J., Blamey, R., and Walton, P. (1995) Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer. Lancet 345, 29-30
4. Howell, A., Robertson, J. F., Quaresma Albano, J., Aschermannova, A., Mauriac, L., Kleeberg, U. R., Vergote, I., Webster, A., and Morris, C. (2002) Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J. Clin. Oncol. 20, 3396-3403
5. Gottardis, M. M., Jiang, S. Y., Jeng, M. H., and Jordan, V. C. (1989) Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antioestrogens. Cancer Res. 49, 4090-4093
6. Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McClelland, R. A., Manning, D. L., and Nicholson, R. I. (1995) Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. J. Natl. Cancer Inst. 87, 746-750
7. Clarke, R., Skaar, T. C., Bouker, K. B., Davis, N., Lee, Y. R., Welch, J. N., and Leonessa, F. (2001) Molecular and pharmacological aspects of antiestrogen resistance. J. Steroid Biochem. Mol. Biol. 76, 71-84
8. Sommer, A., Hoffmann, J., Lichtner, R., Schneider, M. R., and Parczyk, K. (2003) Studies on the development of resistance to the pure antiestrogen Faslodex™ in three human breast cancer cell lines. J. Steroid Biochem. Mol. Biol. 85, 33-47
9. Brown, P. O., and Botstein, D. (1999) Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21 (1 suppl.), 33-37
10. Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C., Lashkari, D., Shalon, D., Brown, P. O., and Botstein, D. (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. U. S. A. 96, 9212-9217
11. Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., Pergamenschikov, A., Lee, J. C., Lashkari, D., Shalon, D., Myers, T. G., Weinstein, J. N., Botstein, D., and Brown, P. O. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227-235
12. Charpentier, A. H., Bednarek, A. I. C., Daniel, R. L., Hawkins, K. A., Laflin, K. J., Gaddis, S., MacLeod, M. C., and Aldaz, C. M. (2000) Effects of estrogen on global gene expression: Identification of novel targets of estrogen action. Cancer Res. 60, 5977-5983
13. Brenton, J. D., Aparicio, S. A., and Caldas, C. (2001) Molecular profiling of breast cancer: Portraits but not physiognomy. Breast Cancer Res. 3, 77-80
14. Gruvberger, S., Ringner, M., Chen, Y., Panavally, S., Saal, L. H., Borg, A., Ferno, M., Peterson, C., and Meltzer, P. S. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979-5984
15. Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Thorsen, T., Quist, H., Matese, J. C., Brown, P. O., Botstein, D., Eystein Lonning, P., and Borresen-Dale, A. L. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98, 10869-10874
16. Hondermarck, H., Vercoutter-Edouart, A. S., Revillion, F., Lemoine, J., El-Yazidi-Belkoura, I., Nurcombe, V., and Peyrat, J. P. (2001) Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 1, 1216-1232
17. Hondermarck, H., Dolle, L., El Yazidi-Belkoura, I., Vercoutter-Edouart, A. S., Adriaenssens, E., and Lemoine, J. (2002) Functional proteomics of breast cancer for signal pathway profiling and target discovery. J. Mammary Gland Biol. Neoplasia 7, 395-405
18. Adriaenssen, E., Lemoine, J., El Yazidi-Belkoura, I., and Hondermarck, H. (2002) Growth signaling in breast cancer cells: Outcomes and promises of proteomics. Biochem. Pharmacol. 64, 797-803
19. Yazidi-Belkoura, I. E., Adriaenssens, E., Vercoutter-Edouart, A. S., Lemoine, J., Nurcombe, V., and Hondermarck, H. (2002) Proteomics of breast cancer: Outcomes and prospects. Technol. Cancer Res. Treat. 1, 287-296
20. Hondermarck, H. (2003) Breast cancer: When proteomics challenges biological complexity. Mol. Cell. Proteomics 2, 281-291
21. Celis, J. E., Gromov, P., Gromova, I., Moreira, J. M., Cabezón, T., Ambartsumian, N., Grigorian, M., Lukanidin, E., Thor Straten, P., Guldberg, P., Bartkova, J., Bartek, J., Lukas, J., Lukas, C., Lykkesfeldt, A., Jäättelä, M., Roepstorff, P., Bolund, L., Ørntoft, T., Brünner, N., Overgaard, J., Sandelin, K., Blichert-Toft, M., Mouridsen, H., and Rank, F. E. (2003) Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. Mol. Cell. Proteomics 2, 369-377
22. Giometti, C. S., Williams, K., and Tollaksen, S. L. (1997) A two-dimensional electrophoresis database of human breast epithelial cell proteins. Electrophoresis 18, 573-581
23. Williams, K., Chubb, C., Huberman, E., and Giometti, C. S. (1998) Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 19, 333-343
24. Rasmussen, R. K., Ji, H., Eddes, J. S., Zugaro, L. M., Reid, G. E., Simpson, R. J., and Dorow, D. S. (1998) Two-dimensional gel database of human breast carcinoma cell expressed proteins: An update. Electrophoresis 19, 818-825
25. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J., Cramer, R., Waterfield, M. D., and Timms, J. F. (2002) Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 1, 91-98
26. Pucci-Minafra, I., Fontana, S., Cancemi, P., Alaimo, G., and Minafra, S. (2002) Proteomic patterns of cultured breast cancer cells and epithelial mammary cells. Ann. N. Y. Acad. Sci. 963, 122-139
27. Pucci-Minafra, I., Fontana, S., Cancemi, P., Basirico, L., Caricato, S., and Minafra, S. (2002) A contribution to breast cancer cell proteomics: Detection of new sequences. Proteomics 2, 919-927
28. Franzen, B., Linder, S., Alaiya, A. A., Eriksson, E., Uruy, K., Hirano, T., Okuzawa, K, and Auer, G. (1996) Analysis of polypeptide expression in benign and malignant human breast lesions: Down-regulation of cytokeratins. Br. J. Cancer. 74, 1632-1638
29. Franzen, B., Linder, S., Alaiya, A. A., Eriksson, E., Fujioka, K., Bergman, A. C., Jornvall, H., and Auer, G. (1997) Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis 18, 582-587
30. Bini, L., Magi, B., Marzocchi, B., Arcuri, F., Tripodi, S., Cintorino, M., Sanchez, J. C., Frutiger, S., Hughes, G., Pallini, V., Hochstrasser, D. F., and Tosi, P. (1997) Protein expression profiles in human breast ductal carcinoma and histologically normal tissue. Electrophoresis 18, 2832-2841
31. Bergman, A. C., Benjamin, T., Alaiya, A., Waltham, M., Sakaguchi, K., Franzen, B., Linder, S., Bergman, T., Auer, G., Appella, E., Wirth, P. J., and Jornvall, H. (2000) Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis 21, 679-686
32. Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H., McLean, K., McGarvey, K., Knowlton, M., Chen, S., Shu, H., Sahin, A., Kurek, R., Wallwiener, D., Merino, M. J., Petricoin, E., III, Zhao, Y., and Steeg, P. S. (2002) Proteomics of human breast ductal carcinoma in situ. Cancer Res. 62, 6740-6749
33. Page, M. J., Amess, B., Townsend, R. R., Parekh, R., Herath, A., Brusten, L., Zvelebil, M. J., Stein, R. C., Waterfield, M. D., Davies, S. C., and O'Hare, M. J. (1999) Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc. Natl. Acad. Sci. U. S. A. 96, 12589-12594
34. Adam, P. J., Boyd, R., Tyson, K. L., Fletcher, G. C., Stamps, A., Hudson, L., Poyser, H. R., Redpath, N., Griffiths, M., Steers, G., Harris, A. L., Patel, S., Berry, J., Loader, J. A., Townsend, R. R., Daviet, L., Legrain, P., Parekh, R., and Terrett, J. A. (2003) Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J. Biol. Chem. 278, 6482-6489
35. Chen, S. T., Pan, T. L., Tsai, Y. C., and Huang, C. M. (2002) Proteomics reveals protein profile changes in doxorubicin-treated MCF-7 human breast cancer cells. Cancer Lett. 181, 95-107
36. Celis, J. E., Kruhoffer, M., Gromova, I., Frederiksen, C., Ostergaard, M., Thykjaer, T., Gromov, P., Yu, J., Palsdottir, H., Magnusson, N., and Ørntoft, T. F. (2000) Gene expression profiling: Monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Lett. 480, 2-16
37. Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19, 1720-1730
38. Ørntoft, T. F., Thykjaer, T., Waldman, F. M., Wolf, H., and Celis, J. E. (2002) Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol. Cell. Proteomics 1, 37-45
39. Anderson, L., and Seilhamer, J. (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533-537
40. Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., and Hood, L. (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292, 929-934
41. Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D. E., Lescure, P., Geiger, J. D., Hanash, S., and Beretta, L. (2001) Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276, 17920-17931
42. Chen, G., Gharib, T. G., Huang, C. C., Thomas, D. G., Shedden, K. A., Taylor, J. M., Kardia, S. L., Misek, D. E., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2002) Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2298-2305
43. Chen, G., Gharib, T. G., Huang, C. C., Taylor, J. M., Misek, D. E., Kardia, S. L., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1, 304-313
44. Griffin, T. J., Gygi, S. P., Ideker, T., Fist, B., Eng, J., Hood, L., and Aebersold, R. (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 1, 323-333
45. Hanash, S. M., Bobek, M. P., Rickman, D. S., Williams, T., Rouillard, J. M., Kuick, R., and Puravs, E. (2002) Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2, 69-75
46. Fessler, M. B., Malcolm, K. C., Duncan, M. W., and Worthen, G. S. (2002) A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. 277, 31291-31302
47. Washburn, M. P., Koller, A., Oshiro, G., Ulaszek, R. R., Plouffe, D., Deciu, C., Winzeler, E., and Yates, J. R., III. (2003) Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 100, 3107-3112
48. Imam-Sghiouar, N., Laude-Lemaire, I., Labas, V., Pflieger, D., Le Caer, J. P., Caron, M., Nabias, D. K., and Joubert-Caron, R. (2002) Subproteomics analysis of phosphorylated proteins: Application to the study of B-lymphoblasts from a patient with Scott syndrome. Proteomics 2, 828-838
49. Djelloul, S., Tarunina, M., Barnouin, K., Mackay, A., and Jat, P. S. (2002) Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63 family of proteins in replicative senescence. Oncogene 21, 981-989
50. Autieri, M. V., and Carbone, C. J. (1999) 14-3-3-gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA Cell Biol. 18, 555-564
51. Brattsand, G. (2000) Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br. J. Cancer 83, 311-318
52. Pradet-Balade, B., Boulme, F., Beug, H., Mullner, E. W., and Garcia-Sanz, J. A. (2001) Translation control: Bridging the gap between genomics and proteomics? Trends Biochem. Sci. 26, 225-229
53. Cuozzo, J. W., Toa, K., Cygler, M., Mort, J. S., and Sahagian, G. G. (1998) Lysine-based structure responsible for selective mannose phosphorylation of cathepsin D and cathepsin L defines a common structural motif for lysosomal enzyme targeting. J. Biol. Chem. 273, 21067-21076
54. Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., and Di Fronzo, G. (1998) Genistein in the control of breast cancer cell growth: Insights into the mechanism of action in vitro. Cancer Lett. 130, 143-152
55. Westley, B., and Rochefort, H. (1980) A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20, 353-362
56. Westley, B. R., and May, F. E. (1987) Oestrogen regulates cathepsin D mRNA levels in oestrogen responsive human breast cancer cells. Nucleic Acids Res. 15, 3773-3786
57. May, F. E., and Westley, B. R. (1995) Estrogen regulated messenger RNAs in human breast cancer cells. Biomed. Pharmacother. 49, 400-414
58. Zhu, A. X., Zhao, Y., and Flier, J. S. (1994) Molecular cloning of two small GTP-binding proteins from human skeletal muscle. Biochem. Biophys. Res. Commun. 205, 1875-1882
59. Gromov, P. S., Celis, J. E., Hansen, C., Tommerup, N., Gromova, I., and Madsen, P. (1998) Human rab11 a: Transcription, chromosome mapping and effect on the expression level of host GTP-binding proteins. FEBS Lett. 429, 359-364
60. Chen, D., Ganapathy, P., Zhu, L.-J., Xu, X., Li, Q., Bagchi, I. C., and Bagchi, M. K. (1999) Potential regulation of membrane trafficking by estrogen receptor α via induction of Rab11 in uterine glands during implantation. Mol. Endocrinol. 13, 993-1004
61. van der Bliek, A. M. (1999) Functional diversity in the dynamin family. Trends Cell Biol. 9, 96-102
62. Horisberger, M. A. (1992) Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66, 4705-4709
63. Nakade, K., Handa, H., and Nagata, K. (1997) Promoter structure of the MxA gene that confers resistance to influenza virus. FEBS Lett. 418, 315-318
64. Ronni, T., Matikainen, S., Lehtonen, A., Palvimo, J., Dellis, J., Van Eylen, F., Goetschy, J. F., Horisberger, M., Content, J., and Julkunen, I. (1998) The proximal interferon-stimulated response elements are essential for interferon responsiveness: A promoter analysis of the antiviral MxA gene. J. Interferon Cytokine Res. 18, 773-781
65. Levy, D. E., and Darnell, J. E. Jr. (2002) Stats: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651-662
66. Thompson, D. A., and Weigel, R. J. (1998) hAG-2, the human homologue of Xenopus laevis anterior gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem. Biophys. Res. Commun. 251, 111-116
67. Fletcher, G. C., Patel, S., Tyson, K., Adam, P. J., Schenker, M., Loader, J. A., Daviet, L., Legrain, P., Parekh, R., Harris, A. L., and Terrett, J. A. (2003) hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br. J. Cancer 88, 579-585